Monday, June 8th, 2026

DDA directs withdrawal of substandard drugs from the market



KATHMANDU: The Department of Drug Administration has given instructions to withdraw the drug Zincomin-DT in the market.

After the medicine was found to be of low quality, the department instructed Nova Genetica Pvt Ltd Khanikhola-7, Naubise, Dhading to recall the medicine.

Issuing a notice on Sunday, DDA directed to recall the medicine and ensured that Zincomin will be returned, not sold and distributed as the medicine did not comply with respect to disintegration test carried out after the market monitoring.

The Department also instructed the medical practitioners not to recommend Nova’s Zincomin.

Publish Date : 28 August 2022 15:28 PM

Opposition leaders attend RSP-called all-party meeting; Shram Sanskriti Party boycotts

KATHMANDU: Key opposition and parliamentary leaders have joined an all-party

Israel vows retaliation after first Iranian attack since April

TEL AVIV: Israel has warned that it will respond to

Has Nepal-India relation truly been ‘reset’? Experts say not yet

KATHMANDU: A debate has emerged over the meaning of a

Revisiting Last week: Diplomacy, Debates, and Direction

KATHMANDU: The past week was one of the most consequential